pemetrexed /carboplatin Clinical Trials

5 actively recruiting trials across 2 locations

No change since May 2026

Pipeline

Phase 1: 1Phase 2: 3Phase 1/2: 1

Top Sponsors

Vivace Therapeutics, Inc1
Sichuan University1
Shenyang Sunshine Pharmaceutical Co., LTD.1
Betta Pharmaceuticals Co., Ltd.1
AstraZeneca1

Indications

Cancer5
Lung Cancer3
NSCLC2
Adjuvant Drug Therapy1
First-line Advanced NSCLC Patients1

Other3 trials

A Phase II Study of SSGJ-706 Monotherapy and Combination Therapy in Advanced Non-Small Cell Lung Cancer（NSCLC） Patients

Phase 2

Application of KRAS Vaccine in the Treatment of KRAS-mutated Malignancies

Phase 1

Sequential Chemotherapy With Befotertinib in Non-Small Cell Lung Cancer (NSCLC) Patients With Resistance to Third-Generation EGFR-TKI

Phase 2

Little Rock, Arkansas1 trial

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

Research Site

Phase 2

San Francisco, California1 trial

Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors

UCSF Helen Diller Family Comprehensive Cancer Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.